Reagent Parameters for BS400/420 Chemistry Analyzer

Linearity
Reac Direc- Preci- Pri. Sec. S R1 R2 Linear Blank. Incuba. Sub- Anti- Range
No. Time Time Rule
Type. strate gen
tion Unit sion Wave Wave (µl) (µl) (µl) Limit Limit excess Up Low

ALT 401 Kinetic Decrease U/L 0.1 340 412 10 200 50 0.2 / 50-69 4800 / 1000 4 Two-piont linear

AST 402 Kinetic Decrease U/L 0.1 340 412 10 200 50 / / 50-69 5700 / 800 4 Two-piont linear

ALP 403 Kinetic Increase U/L 0.1 412 546 4 200 50 0.2 / 50-69 20000 / 800 5 Two-piont linear

γ-GT 404 Kinetic Increase U/L 0.1 412 546 20 200 50 0.2 / 50-69 17200 / 650 4 Two-piont linear

TP 408 Endpoint Increase g/L 0.1 546 605 4 200 / / 10-12 77-79 / / 120 2 Two-piont linear

ALB 409 Endpoint Increase g/L 0.1 570 505 2 200 / / 10-12 44-46 / / 60 3 Two-piont linear

T-Bil-V 406 Endpoint Decrease µmol/L 0.1 450 546 7 196 49 / 40-42 77-79 / / 684 2 Two-piont linear

D-Bil-V 407 Endpoint Decrease µmol/L 0.1 450 546 7 196 49 / 40-42 77-79 / / 430 1 Two-piont linear

T-Bil-D 444 Endpoint Increase µmol/L 0.01 546 660 20 200 / / 10-12 77-79 / / 600 1.7 Two-piont linear

D-Bil-D 445 Endpoint Increase µmol/L 0.01 546 660 20 200 / / 10-12 24-26 / / 260 1 Two-piont linear

TBA 432 Kinetic Increase µmol/L 0.1 412 505 3 203 68 0.2 / 50-69 30000 / 180 2 Two-piont linear

PA 431 Endpoint Increase mg/L 0.1 340 / 7 200 75 / 40-42 77-79 / / 800 10 SPLINE

CHE 452 Kinetic Decrease U/L 1 412 700 4 250 50 0.2 / 49-59 / / 20000 400 Two-piont linear
AFU 438 Kinetic Increase U/L 0.01 412 / 25 225 / 0.2 / 33-53 / / 300 0.5 K factor
ADA 436 Kinetic Increase U/L 0.01 546 / 5 180 90 0.2 / 63-77 / / 200 1 Two-piont linear
5'-NT 437 Kinetic Increase U/L 0.01 546 / 10 180 90 0.2 / 63-77 / / 300 0.5 Two-piont linear

UA 412 Endpoint Increase µmol/L 0.1 546 700 5 240 60 / 40-42 77-79 / / 1500 20.8 Two-piont linear

UREA 413 Fixed Time Decrease mmol/L 0.01 340 700 2 200 50 / / 47-57 8000 / 40 1 Two-piont linear

CREA-J 410 Fixed Time Increase µmol/L 0.1 505 700 16 160 160 / / 46-59 27000 / 2420 9 Two-piont linear

CREA-S 411 Endpoint Increase µmol/L 0.1 546 700 6 180 60 / 40-42 77-79 / / 9000 10 Two-piont linear

MALB 460 Endpoint Increase mg/L 0.1 340 / 16 250 40 / 40-41 74-75 / / 4 300 Spline
RBP 463 Endpoint Increase mg/dL 0.01 605 / 4 180 60 / 44-46 70-73 / / 0.35 25 Spline
Glu-God 415 Endpoint Increase mmol/L 0.01 505 660 3 240 60 / 40-42 77-79 / / 28 0.3 Two-piont linear

Glu-HK 414 Endpoint Increase mmol/L 0.01 340 700 2 167 84 / 40-42 77-79 / / 33 0.6 Two-piont linear

FUN 454 Kinetic Increase µmol/L 0.1 546 700 20 200 50 0.2 / 72-80 / / 1000 5 Two-piont linear

Hb 455 Endpoint Increase µmol/L 0.1 505 800 12 180 / / 10-12 44-46 / / 310 / Two-piont linear

HbA1C 446 Endpoint Increase µmol/L 0.1 660 800 12 180 60 / 40-42 77-79 / / / / Two-piont linear
β2-mG 435 Fixed Time Increase mg/L 0.01 546 / 3 240 60 / / 46-59 / / 18 0.2 Two-piont linear
CysC 433 Endpoint Decrease mg/L 0.001 546 660 3 240 60 / 44-44 75-77 / / 8 0.2 SPLINE
β-HB 465 Endpoint Increase mmol/L 0.01 505 700 6 200 50 / 41-41 73-73 / / 0.03 5.5 Two-piont linear
 Linearity
Reac Direc- Preci- Pri. Sec. S R1 R2 Linear Blank. Incuba. Sub- Anti- Range
No. Time Time Rule
Type. strate gen
tion Unit sion Wave Wave (µl) (µl) (µl) Limit Limit excess Up Low

TC 416 Endpoint Increase mmol/L 0.01 505 700 2 200 / / 10-12 44-46 / / 20 0.1 Two-piont linear

TG 417 Endpoint Increase mmol/L 0.01 505 700 2 200 / / 10-12 77-79 / / 12.5 0.1 Two-piont linear

HDL-C 421 Endpoint Increase mmol/L 0.01 605 700 3 225 75 / 40-42 77-79 / / 6 0.05 Two-piont linear

LDL-C 420 Endpoint Increase mmol/L 0.01 605 700 3 225 75 / 40-42 77-79 / / 25.8 0.05 Two-piont linear

ApoA1 418 Endpoint Increase g/L 0.01 340 / 2 200 67 / 40-42 77-79 / / 2.3 0.2 Logit 5P

ApoB 419 Endpoint Increase g/L 0.01 340 / 2 200 67 / 40-42 77-79 / / 2.2 0.2 Logit 5P

Lp(a) 430 Endpoint Increase mg/L 0.01 340 / 12 200 20 / 40-42 77-79 / / 1000 40 Logit 4P

HCY 447 Endpoint Increase µmol/L 0.1 660 700 20 200 30 / 40-42 77-79 / / 40 1 Two-piont linear

LDH 427 Kinetic Increase U/L 0.1 340 700 10 240 60 0.2 / 50-69 11500 / 1000 4 Two-piont linear

α-HBDH 405 Kinetic Decrease U/L 0.1 340 546 10 240 60 0.2 / 50-69 1700 / 1000 10 Two-piont linear

CK 425 Kinetic Increase U/L 0.1 340 546 5 200 50 / / 63-80 18800 / 1000 5 Two-piont linear

CK-MB 426 Kinetic Increase U/L 0.1 340 546 10 200 50 0.2 / 63-80 11700 / 600 5 Two-piont linear

D-Dimer 457 Endpoint Increase mg/L 0.01 700 / 4 180 60 / 45-46 71-73 / / 0.5 48 Spline
MYO 458 Endpoint Increase ng/mL 0 570 800 5 150 50 / 43-44 71-73 / / 15 800 Spline
ACE 464 Kinetic Decrease U/L 0.1 340 380 12 150 / / / 42-80 / / 12 150 Two-piont linear

IgA 441 Endpoint Increase g/L 0.01 340 / 3 200 100 / 40-42 77-79 / / 5.6 0.2 Logit 5P

IgG 443 Endpoint Increase g/L 0.01 660 / 3 200 100 / 40-42 77-79 / / 35 0.3 Logit 5P

IgM 442 Endpoint Increase g/L 0.01 340 / 3 200 50 / 40-42 77-79 / / 4.8 0.05 Logit 5P

IgE 459 Endpoint Increase IU/mL 0.01 570 800 15 160 80 / 43-44 71-73 / / 25 1000 Spline
C3 439 Endpoint Increase g/L 0.01 340 / 3 200 100 / 40-42 77-79 / / 3.3 0.04 Logit 5P

C4 440 Endpoint Increase g/L 0.001 340 / 3 200 75 / 40-42 77-79 / / 0.8 0.02 SPLINE

CRP 429 Endpoint Increase mg/L 0.1 340 / 17 200 50 / 40-42 77-79 / / 150 2 Logit 5P
HS-CRP 434 Endpoint Increase mg/L 0.0001 570 700 3 150 150 / 45-45 75-77 / / 320 0.2 SPLINE

ASO 449 Fixed Time Increase IU/ml 0.1 570 800 3 150 150 / / 50-77 / / 1000 20 Two-piont linear

RF 450 Fixed Time Increase IU/ml 0.1 505 800 6 180 60 / / 46-60 / / 120 4 SPLINE

Ca 422 Endpoint Increase mmol/L 0.01 660 700 2 200 / / 10-12 20-22 / / 3.75 0.1 Two-piont linear

Mg 423 Endpoint Increase mmol/L 0.01 505 605 2 200 / / 10-12 44-46 / / 2.05 0.04 Two-piont linear

P 424 Endpoint Increase mmol/L 0.01 340 546 2 200 / / 10-12 44-46 / / 4 0.3 Two-piont linear

Fe 453 Endpoint Increase µmol/L 0.1 570 700 20 250 50 / 40-42 48-50 / / 200 0.9 Two-piont linear

TRF 462 Endpoint Increase g/L 0.01 340 / 2 200 20 / 40-41 74-75 / / 0.5 4.5 Spline
FER 461 Endpoint Increase ng/mL 0 570 800 7.5 150 75 / 43-44 62-66 / / 10 1000 Spline
 Linearity
Reac Direc- Preci- Pri. Sec. S R1 R2 Linear Blank. Incuba. Sub- Anti- Range
No. Time Time Rule
Type. strate gen
tion Unit sion Wave Wave (µl) (µl) (µl) Limit Limit excess Up Low

UIBC 467 Endpoint Increase µmol/L 0.1 570 700 12 200 50 / 40-42 77-79 / / 3.0 100 Two-piont linear

CO2 451 Fixed Time Decrease mmol/L 0.01 412 505 3 300 / / / 20-40 / / 50 1 Two-piont linear

α-AMY 428 Kinetic Increase U/L 0.1 412 570 5 200 50 0.2 / 50-64 19500 / 1500 5 Two-piont linear

LIP 448 Kinetic Increase U/L 0.1 570 700 2 200 40 0.2 / 56-70 / / 250 5 Two-piont linear

G6PD 466 Kinetic Increase U/L 0 340 412 10 200 50 / / 49-63 / / 0 3000 K factor

（1）The aim of using the sec. Wave’s is to elimination the noise of instrument,astigmatism and the interference.
Note：
（2）T-bil(DSA) and D-bil(DSA)’s working solution must be prepared before use. To prepare the working solution, mix 4 parts R1 with 1 part R2.
（3）T-Bil-V（T-Bil-VOX Method）,D-Bil-V（D-Bil-VOX Method）,T-Bil-D（T-Bil-DSA Method）,D-Bil-D（D-Bil-DSA Method）,CREA-J（Modified Jaffé
Method）,CREA-S（CREA-Sarcosine Oxidase Method）,Glu-God（Glu-GOD-POD Method）,Glu-HK（Glu-HK Method）.
（4） Set UIBC parameters according to the following steps: set "Slope" as "-1" in "Parameters", then select "Compensate Results after Test" in
"Setup", click "Save" button below.

P/N：0040-20-32372（12.0）